Royce Small-Cap Fund FY 2025: What Worked

Five of the Fund's 10 equity sectors made a positive impact on calendar year performance, led by Industrials, Financials, and Information Technology. Alamos Gold's positive earnings outlook, a renewed stock buyback program, and rising gold prices all helped its stock to climb throughout 2025. Management reported a 48% increase in total revenue for 1Q25 compared to 1Q24, driven by OCS liver and heart transplants.

Seeking Alpha • Mar 9, 2026

Wall Street Analysts Think Enovis (ENOV) Could Surge 76.62%: Read This Before Placing a Bet

The mean of analysts' price targets for Enovis (ENOV) points to a 76.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research • Mar 5, 2026

Enovis Corporation (ENOV) Q4 2025 Earnings Call Transcript

Enovis Corporation (ENOV) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 27, 2026

One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings

Front Street added 156,069 shares of Enovis in the fourth quarter. The quarter-end position value increased by $3.40 million, reflecting both trading activity and share price changes.

The Motley Fool • Feb 26, 2026

Enovis Announces Fourth Quarter and Full Year 2025 Results

Dallas, TX, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and full year ended December 31, 2025. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET.

GlobeNewsWire • Feb 26, 2026

Update: Enovis Announces Fourth Quarter and Full Year 2025 Results

Dallas, TX, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and full year ended December 31, 2025. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET.

GlobeNewsWire • Feb 26, 2026

Enovis (ENOV) Q4 Earnings Beat Estimates

Enovis (ENOV) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.98 per share a year ago.

Zacks Investment Research • Feb 26, 2026

Enovis: Valuation Is Too Low, But Needs To Differentiate On Growth

Enovis continues to struggle in the market, as institutional investors just aren't interested in mid-single-digit growth from a mid-cap name. Management has guided for up to low-double-digit Recon growth in 2026, but overall growth, margin leverage, and meaningful free cash flow generation remain key hurdles for rerating. Bringing successful products over from Europe could drive more growth in hips and shoulders, but it will take time and clinical trials to get them to the market.

Seeking Alpha • Feb 12, 2026

Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Dallas TX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 11, 2026 in Snowbird, UT. About Enovis Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life.

GlobeNewsWire • Feb 3, 2026

Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th

Dallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2025 financial results on Thursday, February 26th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com.

GlobeNewsWire • Jan 23, 2026